Gingivitis: Development and Evaluation of Drugs for Treatment or Prevention
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 28, 2005
February 3, 2025
bec1ab26-9d0e-468e-ac35-7797add101ae
Related Documents
Migraine: Developing Drugs for Preventive Treatment
Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
Alcoholism: Developing Drugs for Treatment
Guidance DocumentFebruary 12, 2015Center for Drug Evaluation and Research
Public Availability of Labeling Changes in "Changes Being Effected" Supplements
Guidance DocumentSeptember 20, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox